British Journal of Cancer

Fig. 2 | British Journal of Cancer

Fig. 2

From: Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

Fig. 2

Search

Advanced search

Quick links